News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily3d agobullish
This Former Mylan/Pfizer Combo Just Topped Its Buy Zone - What You Should KnowMT Newswires4d agoneutral
UBS Adjusts Pfizer Price Target to $30 From $27, Maintains Neutral RatingMT Newswires4d agoneutral
RBC Raises Price Target on Pfizer to $28 From $25, Keeps Sector Perform RatingBarrons.com4d agoneutral
Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity MarketGuruFocus.com4d agoneutral
Pfizer Inc (PFE) (Q3 2026) Earnings Call Highlights: Raised Guidance, Cost Savings Momentum, ...Investor's Business Daily5d agoneutral
Pfizer CEO Touts $80 Billion In Deals - But 'The Real Test' Is Still AheadBarrons.com5d agoneutral
Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs.